2x founder

Armand Cognetta

Founder and CEO, General Proximity—jobs.generalproximity.bio

Founder

General Proximity· Winter 2020 🇺🇸 San Francisco, California, United States

in LinkedIn 𝕏 @armandcognetta

2021Mentor, Longevity Biotech· On Deck

Founder · since 2019

Company

On Deck

Role

Mentor, Longevity Biotech

Stage

—

no public source

Raised

—

no public source

Based

—

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

General Proximity

The next generation of induced-proximity medicines.

Winter 2020

Experience

Career

General Proximity
Founder
Founder and CEO · San Francisco Bay Area · 2019 – Present
2019
Menten AI
Scientific Advisor · 2020 – Present
2020
On Deck
Mentor, Longevity Biotech · 2021 – 2023
2021
Y Combinator
Founder
Founder – W20 · 2020
2020
Inzen Therapeutics
Scientist · New York, New York, United States · 2018 – 2019
2018
Scripps Research
Research Technician · San Diego, California, United States · 2011 – 2013
2011
Alnylam Pharmaceuticals
Research Intern · Cambridge, Massachusetts, United States · 2010 – 2011
2010

Bio

Armand completed his PhD in Chemical Biology at the Scripps Research Institute under the supervision of Dr. Benjamin F. Cravatt. There he co-authored 19 scientific publications in prestigious journals such as Cell, Nature, and Science, as well as multiple patents, including a portion of the foundational IP for Abide Therapeutics (acq. Lundbeck) and Vividion Therapeutics (acq. Bayer). Prior to founding GP he was an early employee at the Flagship Pioneering start-up Inzen Tx (now Sonata).